Mutant Caveolin-3 Induces Persistent Late Sodium Current and Is Associated With Long-QT Syndrome
Top Cited Papers
- 14 November 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 114 (20) , 2104-2112
- https://doi.org/10.1161/circulationaha.106.635268
Abstract
Background— Congenital long-QT syndrome (LQTS) is a primary arrhythmogenic syndrome stemming from perturbed cardiac repolarization. LQTS, which affects ≈1 in 3000 persons, is 1 of the most common causes of autopsy-negative sudden death in the young. Since the sentinel discovery of cardiac channel gene mutations in LQTS in 1995, hundreds of mutations in 8 LQTS susceptibility genes have been identified. All 8 LQTS genotypes represent primary cardiac channel defects (ie, ion channelopathy) except LQT4, which is a functional channelopathy because of mutations in ankyrin-B. Approximately 25% of LQTS remains unexplained pathogenetically. We have pursued a “final common pathway” hypothesis to elicit novel LQTS-susceptibility genes. With the recent observation that the LQT3-associated, SCN5A -encoded cardiac sodium channel localizes in caveolae, which are known membrane microdomains whose major component in the striated muscle is caveolin-3, we hypothesized that mutations in caveolin-3 may represent a novel pathogenetic mechanism for LQTS. Methods and Results— Using polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing, we performed open reading frame/splice site mutational analysis on CAV3 in 905 unrelated patients referred for LQTS genetic testing. CAV3 mutations were engineered by site-directed mutagenesis and the molecular phenotype determined by transient heterologous expression into cell lines that stably express the cardiac sodium channel hNa v 1.5. We identified 4 novel mutations in CAV3 -encoded caveolin-3 that were absent in >1000 control alleles. Electrophysiological analysis of sodium current in HEK293 cells stably expressing hNa v 1.5 and transiently transfected with wild-type and mutant caveolin-3 demonstrated that mutant caveolin-3 results in a 2- to 3-fold increase in late sodium current compared with wild-type caveolin-3. Our observations are similar to the increased late sodium current associated with LQT3-associated SCN5A mutations. Conclusions— The present study reports the first CAV3 mutations in subjects with LQTS, and we provide functional data demonstrating a gain-of-function increase in late sodium current.Keywords
This publication has 36 references indexed in Scilit:
- Localization of cardiac L-type Ca2+channels to a caveolar macromolecular signaling complex is required for β2-adrenergic regulationProceedings of the National Academy of Sciences, 2006
- Cryptic 5? splice site activation in SCN5A associated with Brugada syndromeJournal of Molecular and Cellular Cardiology, 2005
- Regulation of the Voltage-Gated Cardiac Sodium Channel Nav1.5 by Interacting ProteinsTrends in Cardiovascular Medicine, 2005
- Contribution of Sodium Channel Mutations to Bradycardia and Sinus Node Dysfunction in LQT3 FamiliesCirculation Research, 2003
- The Cardiac Sodium‐Calcium Exchanger Associates with Caveolin‐3Annals of the New York Academy of Sciences, 2002
- A β 2 Adrenergic Receptor Signaling Complex Assembled with the Ca 2+ Channel Ca v 1.2Science, 2001
- Differential Targeting of β-Adrenergic Receptor Subtypes and Adenylyl Cyclase to Cardiomyocyte CaveolaeJournal of Biological Chemistry, 2000
- Influence of the Genotype on the Clinical Course of the Long-QT SyndromeNew England Journal of Medicine, 1998
- Mutations in the hminK gene cause long QT syndrome and suppress lKs functionNature Genetics, 1997
- A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndromeCell, 1995